Integrating Real-World Data into clinical research is revolutionizing the life sciences industry. Learn more in this portion of 'The Innovation Imperative: The Future of Drug Development,' an independent study conducted by the Economist Intelligence Unit and commissioned by Parexel. http://bit.ly/2QQ7VPS
3:29Dr. Scott Gottlieb, Former Commissioner of the Food and Drug Administration speaks with Parexel’s Peyton Howell, Executive Vice President, Chief Commercial & Strategy Officer and Sy Pretorius, Executi
3:18RWE experts Leanne Larson, Senior Vice President and Worldwide Head, Real-World Evidence and Access and Amy McKee, Vice President, Regulatory and Access dig deeper into the evolving role of RWE.
2:52Dr. Scott Gottlieb, Former Commissioner of the Food and Drug Administration speaks with Parexel’s Peyton Howell, Executive Vice President, Chief Commercial & Strategy Officer and Sy Pretorius, Executi
4:36Dr. Scott Gottlieb, Former Commissioner of the Food and Drug Administration speaks with Parexel’s Peyton Howell, Executive Vice President, Chief Commercial & Strategy Officer and Sy Pretorius, Executi
3:04Chuck Welch, Senior Director of IT Architecture & Engineering, discusses ongoing initiatives within Parexel Infrastructure, his progression within Parexel, and how he spends his free time.
1:09Chuck Welch, Senior Director of IT Architecture & Engineering, discusses the optimization and transformation of resources within his team.
1:02Chuck Welch, Senior Director of IT Architecture & Engineering, shares his gratifying work and progression at Parexel.
0:46Chuck Welch, Senior Director of IT Architecture & Engineering, shares a glimpse of life outside of work.
0:50Roz Round introduces the Parexel Patient Community
2:49Take a look inside Parexel’s Early Phase Clinics and see how we protect the safety of our employees and volunteers during COVID-19.
